Am J Manag Care. 1998 Jan;4 Suppl:S15-9; discussion S20-2.
Many psychiatrist and other mental healthcare professionals consider the availability of atypical antipsychotic drugs a welcome advance in the treatment of schizophrenia. Atypical agents have show to be effective against both positive and negative symptoms of schizophrenia, and in general, their efficacy makes patients more responsive to rehabilitation efforts. Although drugs are a cornerstone of treatment, optimal management of chronic ambulatory outpatients with schizophrenia also depends of psychosocial and other approaches. Still, noncompliance needs to be addressed as schizophrenia patients often fail to take their medications for a variety of reasons, including undesirable side effects and lack of insight or denial of having a mental disorder. A four-vector model for optimal management of chronic ambulatory outpatients includes the biological, psychological, social, and spiritual domains. Although the resources for providing comprehensive, forward-looking management are not universally available in many areas of the United States, clinicians should always strive for the ideal.
许多精神病医生和其他精神卫生保健专业人员认为,非典型抗精神病药物的出现是精神分裂症治疗中一项值得欢迎的进展。非典型药物已被证明对精神分裂症的阳性和阴性症状均有效,总体而言,它们的疗效使患者对康复治疗更有反应。尽管药物是治疗的基石,但对慢性门诊精神分裂症患者的最佳管理还取决于心理社会和其他方法。然而,由于精神分裂症患者常常因各种原因(包括不良副作用以及缺乏洞察力或否认患有精神障碍)而未能服药,因此不依从性问题需要得到解决。慢性门诊患者最佳管理的四要素模型包括生物学、心理学、社会和精神领域。尽管在美国许多地区并非普遍具备提供全面、前瞻性管理的资源,但临床医生应始终追求理想状态。